Guru Ownership Trend
Guru Analysis for Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc. (ACRS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.72 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $1.6 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 62.7%. Conversely, Cliff Asness reduced exposure by 16.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Aclaris Therapeutics, Inc. (ACRS)
Major holders include Renaissance Technologies (RenTech) ($4.32 M), Cliff Asness ($318,771), Jefferies Group ($58,190). According to the latest reported data, 3 tracked investment managers collectively hold approximately 888,790 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.6 M, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ACRS. The total reported sell value was $64,268.39.
Yes, 0 managers opened new positions in ACRS, and 1 increased their existing holdings. The total reported buy value was $1.67 M.